Zusheng Zong

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
A fundamental challenge in cancer genomics is to design effective, personalized treatments based on the mutational profiles of tumors. Pharmacological targeting of the numerous aberrant pathways found in individual tumors remains exceedingly challenging, but T cell-based therapies are an attractive alternative because of the enormous diversity and exquisite(More)
  • 1